FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

443763005: Pazopanib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2010. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2836585010 Pazopanib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2840747015 Pazopanib en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pazopanib Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Pazopanib Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Pazopanib Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Pazopanib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Pazopanib Is a Sulfonamide true Inferred relationship Existential restriction modifier
Pazopanib Is a Aminopyrimidine true Inferred relationship Existential restriction modifier
Pazopanib Is a Indazole true Inferred relationship Existential restriction modifier
Pazopanib Has disposition Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier
Pazopanib Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Pazopanib Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing pazopanib Has active ingredient True Pazopanib Inferred relationship Existential restriction modifier 1
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib Inferred relationship Existential restriction modifier
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib Inferred relationship Existential restriction modifier
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib Inferred relationship Existential restriction modifier 1
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has basis of strength substance False Pazopanib Inferred relationship Existential restriction modifier 1
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib Inferred relationship Existential restriction modifier 1
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has basis of strength substance False Pazopanib Inferred relationship Existential restriction modifier 1
Pazopanib hydrochloride Is a False Pazopanib Inferred relationship Existential restriction modifier
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has precise active ingredient False Pazopanib Inferred relationship Existential restriction modifier 1
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has precise active ingredient False Pazopanib Inferred relationship Existential restriction modifier 1
Product containing pazopanib in oral dose form (medicinal product form) Has active ingredient True Pazopanib Inferred relationship Existential restriction modifier 1
Pazopanib hydrochloride Is modification of True Pazopanib Inferred relationship Existential restriction modifier
Pazopanib Has active ingredient True Pazopanib Inferred relationship Existential restriction modifier 1
Product containing only pazopanib in oral dose form (medicinal product form) Has active ingredient True Pazopanib Inferred relationship Existential restriction modifier 1
Product containing precisely pazopanib (as pazopanib hydrochloride) 200 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier 1
Product containing precisely pazopanib (as pazopanib hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier 1
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib Inferred relationship Existential restriction modifier
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has active ingredient False Pazopanib Inferred relationship Existential restriction modifier
Pazopanib 400mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Pazopanib 200mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Pazopanib 200mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Pazopanib Inferred relationship Existential restriction modifier
Pazopanib 400mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Pazopanib Inferred relationship Existential restriction modifier
Votrient 400mg tablets (GlaxoSmithKline UK Ltd) Has active ingredient False Pazopanib Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has active ingredient False Pazopanib Inferred relationship Existential restriction modifier
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Pazopanib Inferred relationship Existential restriction modifier
Votrient 400mg tablets (GlaxoSmithKline UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Pazopanib 400mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Votrient 400mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Pazopanib 200mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Pazopanib Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Product containing precisely pazopanib 400 milligram/1 each conventional release oral tablet Has basis of strength substance False Pazopanib Inferred relationship Existential restriction modifier
Votrient 400mg tablets (GlaxoSmithKline UK Ltd) 30 tablet Has basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Pazopanib 400mg tablets 30 tablet Has basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Votrient 400mg tablets (GlaxoSmithKline UK Ltd) Has basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Pazopanib 200mg tablets 30 tablet Has basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Product containing precisely pazopanib 200 milligram/1 each conventional release oral tablet Has basis of strength substance False Pazopanib Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) 30 tablet Has basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier
Votrient 200mg tablets (GlaxoSmithKline UK Ltd) Has basis of strength substance True Pazopanib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start